Destiny Pharma plc

AIM:DEST Voorraadrapport

Marktkapitalisatie: UK£4.5m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Destiny Pharma Toekomstige groei

Future criteriumcontroles 0/6

Destiny Pharma's revenue and earnings are forecast to decline at 171.4% and 15.5% per annum respectively while EPS is expected to decline by 13.6% per annum.

Belangrijke informatie

-15.5%

Groei van de winst

-13.6%

Groei van de winst per aandeel

Biotechs winstgroei34.8%
Inkomstengroei-171.4%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerkt15 Jul 2024

Recente toekomstige groei-updates

Recent updates

We're Hopeful That Destiny Pharma (LON:DEST) Will Use Its Cash Wisely

Jan 12
We're Hopeful That Destiny Pharma (LON:DEST) Will Use Its Cash Wisely

Destiny Pharma (LON:DEST) Is In A Good Position To Deliver On Growth Plans

Sep 26
Destiny Pharma (LON:DEST) Is In A Good Position To Deliver On Growth Plans

We Think Destiny Pharma (LON:DEST) Needs To Drive Business Growth Carefully

May 26
We Think Destiny Pharma (LON:DEST) Needs To Drive Business Growth Carefully

Companies Like Destiny Pharma (LON:DEST) Are In A Position To Invest In Growth

Feb 01
Companies Like Destiny Pharma (LON:DEST) Are In A Position To Invest In Growth

Will Destiny Pharma (LON:DEST) Spend Its Cash Wisely?

Aug 05
Will Destiny Pharma (LON:DEST) Spend Its Cash Wisely?

Is Destiny Pharma (LON:DEST) In A Good Position To Invest In Growth?

Apr 16
Is Destiny Pharma (LON:DEST) In A Good Position To Invest In Growth?

What Type Of Shareholders Make Up Destiny Pharma plc's (LON:DEST) Share Registry?

Feb 11
What Type Of Shareholders Make Up Destiny Pharma plc's (LON:DEST) Share Registry?

We're Hopeful That Destiny Pharma (LON:DEST) Will Use Its Cash Wisely

Nov 30
We're Hopeful That Destiny Pharma (LON:DEST) Will Use Its Cash Wisely

Winst- en omzetgroeiprognoses

AIM:DEST - Toekomstschattingen van analisten en financiële gegevens uit het verleden (GBP Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/2025N/A-8N/AN/A1
12/31/2024N/A-6-6-52
12/31/20231-6-6-5N/A
9/30/20231-6-5-5N/A
6/30/20231-6-5-5N/A
3/31/20231-6-6-6N/A
12/31/20220-7-6-6N/A
9/30/20220-6-5-5N/A
6/30/20220-6-5-5N/A
3/31/20220-6-5-5N/A
12/31/20210-5-5-5N/A
9/30/20210-5-7-6N/A
6/30/20210-5-9-6N/A
3/31/20210-5-8-6N/A
12/31/20200-5-8-5N/A
9/30/20200-5-6-5N/A
6/30/20200-5-4-4N/A
3/31/20200-5-4-4N/A
12/31/20190-5-5-5N/A
9/30/20190-5-5-5N/A
6/30/2019N/A-5-6-6N/A
3/31/2019N/A-5-5-5N/A
12/31/2018N/A-5-5-5N/A
9/30/2018N/A-5-4-4N/A
6/30/2018N/A-4-3-3N/A
3/31/2018N/A-4-3-3N/A
12/31/2017N/A-3-2-2N/A
9/30/2017N/A-2N/A-2N/A
6/30/2017N/A-2N/A-1N/A
3/31/2017N/A-1N/A-1N/A
12/31/2016N/A-1N/A-1N/A
12/31/2015N/A-1N/A-1N/A
12/31/2014N/A-2N/A-2N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: DEST is forecast to remain unprofitable over the next 3 years.

Winst versus markt: DEST is forecast to remain unprofitable over the next 3 years.

Hoge groeiwinsten: DEST is forecast to remain unprofitable over the next 3 years.

Omzet versus markt: DEST is forecast to have no revenue next year.

Hoge groei-inkomsten: DEST is forecast to have no revenue next year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if DEST's Return on Equity is forecast to be high in 3 years time

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y